Status:

COMPLETED

A Prospective Munti-center Study on VANGUARD™ PS Total Knee Replacement System

Lead Sponsor:

Zimmer Biomet

Conditions:

Osteoarthritis

Rheumatoid Arthritis

Eligibility:

All Genders

20+ years

Brief Summary

The primary objectives of this pilot clinical study include: * Evaluate clinical outcomes and quality of life on patients who received Vanguard PS Total Knee in Korean population * Evaluate safety of...

Detailed Description

This study is a prospective, single cohort, multi-center study of Vanguard PS system and will be conducted in Korea with 2 institutions. The study will be conducted over a period of 10 years. Patients...

Eligibility Criteria

Inclusion

  • Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis, where one or more compartments are involved.
  • Correction of varus, valgus, or posttraumatic deformity.
  • Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure
  • Need to obtain pain relief and improve function
  • Ability and willingness of the patient to follow instructions, including control of weight and activity level
  • A good nutritional state of the patient, and
  • The patient must have reached full skeletal maturity (at least 18 years old).

Exclusion

  • infection
  • sepsis
  • osteomyelitis
  • Uncooperative patient or patient with neurologic disorders who are incapable of following directions
  • Osteoporosis
  • Metabolic disorders which may impair bone formation
  • Osteomalacia
  • Distant foci of infections which may spread to the implant site
  • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
  • Vascular insufficiency, muscular atrophy, neuromuscular disease
  • Incomplete or deficient soft tissue surrounding the knee

Key Trial Info

Start Date :

July 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2017

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01906177

Start Date

July 1 2012

End Date

July 1 2017

Last Update

June 26 2018

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Gangneung Asan Hospital

Gangneung-Si, Gangwon-do, South Korea, 210-711

2

Chonnam National University Hwasun Hospital

Jeongnam, Jeollanam-do, South Korea, 519-809